Official journal of the Slovak Society of Cardiology,
Slovak Society of Hypertension and Slovak Association for Cardiac Arrhythmias

Cardiology Letters 2021, 30(5):225-230

Comments on 2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease

Farský ©1, Varga I2
Pracovná skupina kardiovaskulárnej rehabilitácie Slovenskej kardiologickej spoločnosti

Published: May 1, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Farský ©, Varga I. Comments on 2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease. Cardiology Letters. 2021;30(5-6):225-230.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Pelliccia A, Sharma S, Gati S, et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur Heart J 2021;42:17-96. http://doi.org/10.1093/eurheartj/ehaa605. Go to original source...
    2. Ambulantná kardiovaskulárna rehabilitácia (AKVR) / sekundárna prevencia (SP). 01.07.2021 https://www.standardnepostupy.sk/prevencia-kardiovaskularnych-ochoreni/
    3. Farsky ©, Rus V, Sládeková K. Ako vykonáva» ambulantnú kardiovaskulárnu rehabilitáciu: návrh Pracovnej skupiny kardiovaskulárnej rehabilitácie Slovenskej kardiologickej spoločnosti. Vnitř Lék 2017;63:969-976. Go to original source...
    4. Várnay F, Homolka P, Mifková L, et al. Stanovení intensity tréninkové zátěľe pro kardiologicky nemocné v rámci kardiovaskulární rehabilitace. In: Spiroergometria v kardiologii a sportovní medicíne. Praha: Grada Publishing; 2020:245-277.
    5. Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2016;37:2315-2381. doi:10.1093/eurheartj/ehw106 Go to original source...
    6. https://u-prevent.com/calculators
    7. Koller A, Laughlin MH, Cenko E, et al. Functional and structural adaptations of the coronary macro- and micro-vasculature to regular aerobic exercise by activation of physiological, cellular and molecular mechanisms. ESC working group on coronary pathophysiology & microcirculation position paper, Cardiovascular Research, 2021; cvab246, https://doi.org/10.1093/cvr/cvab246 Go to original source...
    8. Hanssen H, Boardman H, Deiseroth A, et al. Personalized exercise prescription in the prevention and treatment of arterial hypertension: a Consensus document from the European Association of Preventive Cardiology (EAPC) and the ESC Council on Hypertension, Eur J Prev Cardiol 2021; zwaa141, https://doi.org/10.1093/eurjpc/zwaa141 Go to original source...
    9. Corrado D, Pelliccia A, Bjørnstad HH, et al. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Eur Heart J 2005;26:516-524. doi:10.1093/eurheartj/ehi108 Go to original source...
    10. Pelliccia A, Sharma S, Gati S, et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease: supplementary data. Eur Heart J 2020;00:1-19. doi:10.1093/eurheartj/ehaa605 Go to original source...
    11. van Buuren F, Gati S, Sharma S, et al. Athletes with valvular heart disease and competitive sports: a position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology. Eur J Prev Cardiol 2021; zwab058. https://doi.org/10.1093/eurjpc/zwab058 Go to original source...
    12. Pelliccia A, Solberg EE, Papadakis M, et al. Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC). Eur Heart J 2019;40:19-33. doi:10.1093/eurheartj/ehy730 Go to original source...
    13. Braverman AC, Harris KM, Kovacs RJ, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities. Task force 7: aortic diseases, including Marfan syndrome. A scientific statement from the American Heart Association and American College of Cardiology. Circulation 2015;132:e303-309. doi: 10.1161/CIR.0000000000000243 Go to original source...
    14. SEC working group for the 2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease, Expert reviewers for the 2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease, SEC guidelines committee. Comments on the 2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease. Rev Esp Cardiol 2021;74:488-493.
    15. Chilazi M, Duffy EY, Thakkar A, et al. COVID and cardiovascular disease: what we know in 2021. Curr Atheroscler Rep 2021;23:37. doi: 10.1007/s11883-021-00935-2 Go to original source...
    16. Aboudounya MM, Heads RJ. COVID-19 and toll-like receptor 4 (TLR4): SARS-CoV-2 may bind and activate TLR4 to increase ACE2 expression, facilitating entry and causing hyperinflammation. Mediators Inflamm 2021;2021:8874339. doi: 10.1155/2021/8874339 Go to original source...
    17. Negron SG, Kessinger CW, Xu B, et al. Selectively expressing SARS-CoV-2 spike protein S1 subunit in cardiomyocytes induces cardiac hypertrophy in mice. bioRxiv 2021.06.20.448993. doi: https://doi.org/10.1101/2021.06.20.448993 Go to original source...
    18. Pesce M, Agostoni P, Bøtker HE, et al. COVID-19 related cardiac complications - from clinical evidences to basic mechanisms. Opinion paper of the ESC Working group on cellular biology of the heart. Cardiovasc Res 2021; cvab201. doi: 10.1093/cvr/cvab201 Go to original source...
    19. Daniels CJ, Rajpal S, Greenshields JT, et al. Big Ten COVID-19 cardiac registry investigators. Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection: results from the Big Ten COVID-19 cardiac registry. JAMA Cardiol 2021:e212065. doi: 10.1001/jamacardio.2021.2065. Go to original source...
    20. Bozkurt B, Kamat I, Hotez PJ. Myocarditis with COVID-19 mRNA vaccines. Circulation 2021;144:471-484. doi: 10.1161/CIRCULATIONAHA.121.056135 Go to original source...
    21. Bhatia RT, Marwaha S, Malhotra A, et al. Exercise in the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) era: A question and answer session with the experts endorsed by the section of Sports Cardiology & Exercise of the European Association of Preventive Cardiology (EAPC). Eur J Prev Cardiol 2020;27:1242-1251. doi: 10.1177/2047487320930596 Go to original source...
    22. Tuka V, Sovová E, Jiravská G, et al. Návrat ke sportu u jedinců, kteří se setkali s COVID-19. Společné odborné stanovisko Sekce sportovní kardiologie České asociace preventivní kardiologie ČKS a Sekce sportovní kardiologie České společnosti tělovýchovného lékařství. Cor Vasa 2020;62:427-430. Go to original source...
    23. Laoutaris ID, Dritsas A, Adamopoulos S. Cardiovascular rehabilitation in the COVID-19 era: 'a phoenix arising from the ashes?'. Eur J Prev Cardiol. 2021:zwab116. doi: 10.1093/eurjpc/zwab116 Go to original source...

    Return to the content